Cancer Research and Treatment

Proteomic profiling of ovarian clear cell carcinomas identifies prognostic biomarkers for chemotherapy

Liang Yue, Tingting Gong, Wenhao Jiang, Liujia Qian, Wangang Gong, Yaoting Sun, Xue Cai, Heli Xu, Fanghua Liu, He Wang, Sainan Li, Yi Zhu, Zhiguo Zheng, Qijun Wu, Tiannan Guo

Oncogene‐mediated nuclear accumulation of lactate promotes epigenetic alterations to induce cancer cell proliferation

Shreya Bandopadhyay, Izaz M. Kamal, E. Padmanaban, Damayanti D. Ghosh, Saikat Chakrabarti, Sib S. Roy

Journal of Cellular Biochemistry.2023; 124(4): 495. CrossRef

Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis

Chenlu Wu, Jiafei Ying, Mei Dai, Jing Peng, Danhua Zhang

Journal of Cancer Research and Clinical Oncology.2022; 148(12): 3385. CrossRef

MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells

Zining Liu, Weili Zhang, Biao Zhang, Shaomu Chen, Chunhua Ling

Genetic Testing and Molecular Biomarkers.2022; 26(7-8): 351. CrossRef

Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression

Olivia K. Provance, Eric S. Geanes, Asona J. Lui, Anuradha Roy, Sean M. Holloran, Sumedha Gunewardena, Christy R. Hagan, Scott Weir, Joan Lewis-Wambi

The significance of homeodomain transcription factor 2 in colon cancer cells

Yang He, Peng Gong, Sitong Wang, Qing Xu, Jianhua Chen

BioMedical Engineering OnLine.2021;[Epub] CrossRef

Forkhead-box A3 (FOXA3) Represses Cancer Stemness and Partially Potentiates Chemosensitivity by Targeting Metastasis-Associated in Colon Cancer 1 (MACC1) Signaling Pathway in Colorectal Cancer Cells

Na Li, Yun Li, Hongbo Gao, Jing Li, Xiaoping Ma, Xiaomei Liu, Ping Gong, Xiaobin Cui, Yong Li

Current Cancer Drug Targets.2021; 21(3): 254. CrossRef

PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients

Rudolf Napieralski, Gabriele Schricker, Gert Auer, Michaela Aubele, Jonathan Perkins, Viktor Magdolen, Kurt Ulm, Moritz Hamann, Axel Walch, Wilko Weichert, Marion Kiechle, Olaf G. Wilhelm

Downregulation of PITX2 inhibits the proliferation and migration of liver cancer cells and induces cell apoptosis

Molecular Diagnosis & Therapy.2020; 24(4): 433. CrossRef

Interferon-induced transmembrane protein 1 (IFITM1) is essential for progression of laryngeal squamous cell carcinoma in an Osteopontin/NF-κB-dependent manner

Yong Yin, Keke Yang, Juanjuan Li, Peng Da, Zhenxin Zhang, Xiaoxia Qiu

DNA methylation events in transcription factors and gene expression changes in colon cancer

Anna Díez-Villanueva, Rebeca Sanz-Pamplona, Robert Carreras-Torres, Ferran Moratalla-Navarro, M Henar Alonso, Laia Paré-Brunet, Susanna Aussó, Elisabet Guinó, Xavier Solé, David Cordero, Ramón Salazar, Maria Berdasco, Miguel A Peinado, Victor Moreno

PITX2 enhances progression of lung adenocarcinoma by transcriptionally regulating WNT3A and activating Wnt/β-catenin signaling pathway

Jing Luo, Yu Yao, Saiguang Ji, Qi Sun, Yang Xu, Kaichao Liu, Qiang Diao, Yong Qiang, Yi Shen